Mixture prior distributions and Bayesian models for robust radionuclide image processing [0.03%]
混合先验分布和用于鲁棒核素图像处理的贝叶斯模型
Muyang Zhang,Robert G Aykroyd,Charalampos Tsoumpas
Muyang Zhang
The diagnosis of medical conditions and subsequent treatment often involves radionuclide imaging techniques. To refine localisation accuracy and improve diagnostic confidence, compared with the use of a single scanning technique, a combinat...
Case report: When infection lurks behind malignancy: a unique case of primary bone lymphoma mimicking infectious process in the spine [0.03%]
个案报道：感染背后的恶行——脊柱感染性病变的原发骨淋巴瘤一例
Ayoub Jaafari,Ornella Rizzo,Sohaïb Mansour et al.
Ayoub Jaafari et al.
Primary bone lymphoma of the spine (PBL) is a rare entity that may be misdiagnosed due to its atypical location and clinical and imaging features mimicking certain pathologies as infectious processes, which complicates and delays diagnosis....
Development and validation of radiomic signature for predicting overall survival in advanced-stage cervical cancer [0.03%]
用于预测晚期宫颈癌患者总生存期的影像组学标志物的构建和验证
Ashish Kumar Jha,Sneha Mithun,Umeshkumar B Sherkhane et al.
Ashish Kumar Jha et al.
Background: The role of artificial intelligence and radiomics in prediction model development in cancer has been increasing every passing day. Cervical cancer is the 4th most common cancer in women worldwide, contributing...
Diagnostic accuracy of the latest-generation digital PET/CT scanner for detection of metastatic lymph nodes in head and neck cancer [0.03%]
新一代数字PET/CT检测头颈部肿瘤转移淋巴结的诊断准确性
Frederick Butt,Lillian Dominguez-Konicki,Noah Tocci et al.
Frederick Butt et al.
Purpose: The aim of this retrospective analysis was to assess the diagnostic accuracy of the latest-generation digital positron emission tomography/computed tomography (PET/CT) scanner in the detection of cervical lymph n...
Radiomics insight into the neurodegenerative " hot" brain: A narrative review from the nuclear medicine perspective [0.03%]
核医学视角下的放射组学在神经退行性“热点”脑研究中的见解：一篇叙述性综述
Gayane Aghakhanyan,Gianfranco Di Salle,Salvatore Claudio Fanni et al.
Gayane Aghakhanyan et al.
The application of radiomics for non-oncologic diseases is currently emerging. Despite its relative infancy state, the evidence highlights the potential of radiomics approaches to serve as neuroimaging biomarkers in the field of the neurode...
18F-FDG PET/CT as a molecular biomarker in the diagnosis of amyotrophic lateral sclerosis associated with prostate cancer and progressive supranuclear palsy: A case report [0.03%]
18F-FDG PET/CT在肌萎缩侧索硬化合并前列腺癌及进行性核上性麻痹诊断中的应用：1例报告
Emilly A Cortés Mancera,Fabio A Sinisterra Solis,Francisco R Romero-Castellanos et al.
Emilly A Cortés Mancera et al.
Introduction: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative, multisystem disorder. Its clinical presentation typically consists of progressive focal muscle atrophy and weakness. In addition to motor disorders...
M Vorster,B P Hadebe,M M Sathekge
M Vorster
Introduction: Breast cancer is a complex disease and constitutes the leading cause of cancer in women globally. Conventional treatment modalities include surgery, chemotherapy, radiation therapy, and hormonal therapy; all...
Stephen Harris,James R Crowley,Nancy Warden
Stephen Harris
Background: The nuclear medicine community has stated that they are using best practices to gain venous access and administer radiopharmaceuticals, and therefore do not contribute to extravasations. We tested this hypothe...
Case Report: Post-traumatic splenosis and potential pitfall for PSMA-PET [0.03%]
病例报告：外伤后脾异位症及潜在的PSMA-PET假阳性陷阱
Marina Nearchou,Elizabeth Georgiou,Alexis Vrachimis et al.
Marina Nearchou et al.
Background: 18F-prostate specific membrane antigen (PSMA) PET is fast becoming the gold-standard in prostate cancer, both in staging of intermediate-/high-risk patients and in re-staging patients with biochemical failure....
PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach [0.03%]
胶质母细胞瘤的PET示踪剂：作为个体化医学方法的神经诊疗学研究趋势
Habibullah Dadgar,Narges Jokar,Reza Nemati et al.
Habibullah Dadgar et al.
Over the past decade, theragnostic radiopharmaceuticals have been used in nuclear medicine for both diagnosis and treatment of various tumors. In this review, we carried out a literature search to investigate and explain the role of radiotr...